Europe Extracorporeal Membrane Oxygenation Machine Market Size, Share, Trends & Analysis by Modality (Veno-Venous, Veno-Arterial), by Patient Type (Adult, Neonatal, Pediatric), by Component (Pumps, Cannula, Oxygenator, Controllers) and Region, with Forecasts from 2024 to 2034.

Market Overview

 

The Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market is poised for significant growth from 2024 to 2034, driven by advancements in critical care technologies, the rising prevalence of respiratory and cardiac disorders, and increasing adoption of ECMO in healthcare facilities. ECMO machines, which provide temporary cardiac and respiratory support to patients with severe heart and lung conditions, have become essential in intensive care units (ICUs), especially for patients experiencing acute respiratory distress syndrome (ARDS), cardiogenic shock, and post-cardiac surgery complications. The market is projected to grow at a robust compound annual growth rate (CAGR) of XX.XX% over the forecast period, reaching USD XX.XX billion by 2034 from USD XX.XX billion in 2024. The key market drivers are:

 

• Rising Incidence of Cardiopulmonary Disorders – The increasing prevalence of cardiovascular diseases (CVDs), chronic obstructive pulmonary disease (COPD), and respiratory failure is a key factor driving ECMO machine adoption in European hospitals.

 

• Technological Advancements in ECMO Systems – Innovations such as portable ECMO machines, improved oxygenators, and automation in ECMO management have enhanced patient outcomes, fueling market growth.

 

• Growing Use of ECMO in Neonatal and Pediatric Care – ECMO is increasingly utilized for treating newborns with respiratory failure, congenital diaphragmatic hernia (CDH), and meconium aspiration syndrome, contributing to market expansion.

 

• Increasing Awareness and Adoption in Critical Care – The COVID-19 pandemic highlighted the role of ECMO in managing severe respiratory failure, leading to higher adoption and investments in ECMO infrastructure across Europe.

 

Definition and Scope of ECMO Machines

 

Extracorporeal Membrane Oxygenation (ECMO) is a life-support system that temporarily takes over the function of the heart and lungs, allowing these organs to recover in critically ill patients. The system comprises key components such as pumps, oxygenators, cannulas, and controllers and is classified based on modality (veno-venous, veno-arterial) and patient type (adult, neonatal, pediatric).

 

Market Restraints

 

• High Cost of ECMO Machines and Treatment – The high cost of ECMO systems and associated maintenance expenses can limit their adoption, particularly in smaller healthcare facilities.

 

• Complexity and Need for Specialized Personnel – ECMO requires highly skilled professionals for operation and patient monitoring, leading to challenges in widespread implementation.

 

• Risk of Complications – Patients undergoing ECMO treatment are at risk of bleeding, infections, and thrombosis, which may hinder its adoption in certain cases.

 

Opportunities

 

• Development of Portable ECMO Devices – Innovations in lightweight, portable ECMO machines are expanding their use in emergency and transport settings, improving accessibility.

 

• Integration of AI and Automation – The adoption of AI-driven monitoring and automated ECMO management systems is enhancing efficiency and patient outcomes.

 

• Increasing Healthcare Investments in Europe – Governments and private players are investing in critical care infrastructure, driving demand for ECMO machines in hospitals and specialized care centers.

 

Market Segmentation Analysis

 

• By Modality

    ○ Veno-Venous

    ○ Veno-Arterial

 

• By Patient Type

    ○ Adult

    ○ Neonatal

    ○ Pediatric

 

• By Component

    ○ Pumps

    ○ Cannula

    ○ Oxygenator

    ○ Controllers

 

Regional Analysis

 

• Germany: Leading the ECMO market in Europe due to strong healthcare infrastructure, high adoption of advanced medical technologies, and government investments in critical care.

 

• France: A key market driven by increasing demand for ECMO in cardiac surgery and neonatal care, supported by well-established hospitals and research institutions.

 

• United Kingdom: Rising cases of respiratory and cardiac diseases, along with government initiatives in emergency and ICU care, are fueling market growth.

 

• Italy & Spain: Expanding ECMO adoption due to improving healthcare access, rising medical tourism, and increasing investment in ICU equipment.

 

• Rest of Europe: Emerging economies in Eastern and Northern Europe are witnessing growth due to enhanced healthcare funding and a rising focus on critical care management.

 

The Europe ECMO Machine Market is set for steady expansion, driven by the rising prevalence of cardiopulmonary diseases, technological advancements, and increasing healthcare investments. While cost and complexity remain challenges, the market presents significant growth opportunities through innovations in portable ECMO devices, AI-based monitoring, and expanding neonatal and pediatric applications.

 

Competitive Landscape

 

Key players in the Europe ECMO Machine Market include:

 

Medtronic Plc

Getinge AB

LivaNova Plc

Terumo Corporation

MicroPort Scientific Corporation

Abbott Laboratories

Fresenius Medical Care AG & Co. KGaA

Xenios AG (A Fresenius Company)

Eurosets Srl

Nipro Corporation

Table of Contents:

 

1. Introduction

    1.1. Definition of ECMO Machines

    1.2. Scope of the Report

    1.3. Research Methodology

 

2. Executive Summary

    2.1. Key Findings

    2.2. Market Snapshot

    2.3. Key Trends

 

3. Market Dynamics

    3.1. Market Drivers

        3.1.1. Rising Prevalence of Cardiopulmonary Diseases

        3.1.2. Growing Adoption of ECMO in Critical Care

        3.1.3. Increasing Geriatric Population and Premature Births

        3.1.4. Advancements in ECMO Technology

        3.1.5. Other Market Drivers

    3.2. Market Restraints

        3.2.1. High Cost of ECMO Machines and Procedures

        3.2.2. Risks and Complications Associated with ECMO Therapy

        3.2.3. Shortage of Skilled Healthcare Professionals

        3.2.4. Other Market Restraints

    3.3. Market Opportunities

        3.3.1. Expanding Applications in Pediatric and Neonatal Care

        3.3.2. Growing Research and Clinical Trials on ECMO

        3.3.3. Increasing Investments in Healthcare Infrastructure

        3.3.4. Potential Market Growth in Emerging European Markets

        3.3.5. Other Market Opportunities

 

4. Europe ECMO Machine Market Analysis

    4.1. Market Size and Forecast (2024-2034)

    4.2. Market Share Analysis by:

        4.2.1. Modality

            4.2.1.1. Veno-Venous (VV) ECMO

            4.2.1.2. Veno-Arterial (VA) ECMO

        4.2.2. Patient Type

            4.2.2.1. Adult

            4.2.2.2. Neonatal

            4.2.2.3. Pediatric

        4.2.3. Component

            4.2.3.1. Pumps

            4.2.3.2. Cannula

            4.2.3.3. Oxygenator

            4.2.3.4. Controllers

    4.3. Value Chain Analysis

    4.4. SWOT Analysis

    4.5. Porter’s Five Forces Analysis

 

5. Regional Market Analysis

    5.1. Germany

        5.1.1. Market Overview

        5.1.2. Market Size and Forecast

        5.1.3. Key Trends

        5.1.4. Competitive Landscape

    5.2. United Kingdom

        5.2.1. Market Overview

        5.2.2. Market Size and Forecast

        5.2.3. Key Trends

        5.2.4. Competitive Landscape

    5.3. France

        5.3.1. Market Overview

        5.3.2. Market Size and Forecast

        5.3.3. Key Trends

        5.3.4. Competitive Landscape

    5.4. Italy

        5.4.1. Market Overview

        5.4.2. Market Size and Forecast

        5.4.3. Key Trends

        5.4.4. Competitive Landscape

    5.5. Spain

        5.5.1. Market Overview

        5.5.2. Market Size and Forecast

        5.5.3. Key Trends

        5.5.4. Competitive Landscape

    5.6. Rest of Europe

        5.6.1. Market Overview

        5.6.2. Market Size and Forecast

        5.6.3. Key Trends

        5.6.4. Competitive Landscape

 

6. Competitive Landscape

    6.1. Market Share Analysis of Key Players

    6.2. Company Profiles of Key Players

        6.2.1. Medtronic Plc

        6.2.2. Getinge AB

        6.2.3. LivaNova Plc

        6.2.4. Terumo Corporation

        6.2.5. MicroPort Scientific Corporation

        6.2.6. Abbott Laboratories

        6.2.7. Fresenius Medical Care AG & Co. KGaA

        6.2.8. Xenios AG (A Fresenius Company)

        6.2.9. Eurosets Srl

        6.2.10. Nipro Corporation

    6.3. Recent Developments and Innovations

    6.4. Strategic Initiatives

 

7. Future Outlook and Market Forecast

    7.1. Market Growth Prospects

    7.2. Technological Trends and Innovations

    7.3. Investment Opportunities

    7.4. Strategic Recommendations

 

8. Key Insights and Reiteration of Main Findings

9. Future Prospects for the Europe ECMO Machine Market

 

List of Tables:

 

Table 1: Europe ECMO Machine Market, By Modality, 2024-2034 (USD Million)

Table 2: Europe ECMO Machine Market, By Patient Type, 2024-2034 (USD Million)

Table 3: Europe ECMO Machine Market, By Component, 2024-2034 (USD Million)

Table 4: Europe ECMO Machine Market, By Country, 2024-2034 (USD Million)

Table 5: Germany ECMO Machine Market, By Modality, 2024-2034 (USD Million)

Table 6: Germany ECMO Machine Market, By Patient Type, 2024-2034 (USD Million)

Table 7: Germany ECMO Machine Market, By Component, 2024-2034 (USD Million)

Table 8: U.K. ECMO Machine Market, By Modality, 2024-2034 (USD Million)

Table 9: U.K. ECMO Machine Market, By Patient Type, 2024-2034 (USD Million)

Table 10: U.K. ECMO Machine Market, By Component, 2024-2034 (USD Million)

Table 11: France ECMO Machine Market, By Modality, 2024-2034 (USD Million)

Table 12: France ECMO Machine Market, By Patient Type, 2024-2034 (USD Million)

Table 13: France ECMO Machine Market, By Component, 2024-2034 (USD Million)

Table 14: Italy ECMO Machine Market, By Modality, 2024-2034 (USD Million)

Table 15: Italy ECMO Machine Market, By Patient Type, 2024-2034 (USD Million)

Table 16: Italy ECMO Machine Market, By Component, 2024-2034 (USD Million)

Table 17: Spain ECMO Machine Market, By Modality, 2024-2034 (USD Million)

Table 18: Spain ECMO Machine Market, By Patient Type, 2024-2034 (USD Million)

Table 19: Spain ECMO Machine Market, By Component, 2024-2034 (USD Million)

Table 20: Rest of Europe ECMO Machine Market, By Modality, 2024-2034 (USD Million)

Table 21: Rest of Europe ECMO Machine Market, By Patient Type, 2024-2034 (USD Million)

Table 22: Rest of Europe ECMO Machine Market, By Component, 2024-2034 (USD Million)

Table 23: Europe ECMO Machine Market Revenue by Modality, 2024-2034 (USD Million)

Table 24: Europe ECMO Machine Market Volume by Modality, 2024-2034 (Units)

Table 25: Europe ECMO Machine Market Revenue by Patient Type, 2024-2034 (USD Million)

Table 26: Europe ECMO Machine Market Volume by Patient Type, 2024-2034 (Units)

Table 27: Europe ECMO Machine Market Revenue by Component, 2024-2034 (USD Million)

Table 28: Europe ECMO Machine Market Volume by Component, 2024-2034 (Units)

Table 29: Europe ECMO Machine Market Revenue by Country, 2024-2034 (USD Million)

Table 30: Europe ECMO Machine Market Volume by Country, 2024-2034 (Units)

Table 31: Medtronic plc: Company Snapshot

Table 32: Medtronic plc: Operating Segments

Table 33: Medtronic plc: Product Portfolio

Table 34: Getinge AB: Company Snapshot

Table 35: Getinge AB: Operating Segments

Table 36: Getinge AB: Product Portfolio

Table 37: LivaNova Plc: Company Snapshot

Table 38: LivaNova Plc: Operating Segments

Table 39: LivaNova Plc: Product Portfolio

 

List of Figures:

 

Figure 1: Europe ECMO Machine Market: Market Segmentation

Figure 2: Europe ECMO Machine Market: Research Methodology

Figure 3: Top-Down Approach

Figure 4: Bottom-Up Approach

Figure 5: Data Triangulation and Validation

Figure 6: Europe ECMO Machine Market: Drivers, Restraints, Opportunities, and Challenges

Figure 7: Europe ECMO Machine Market: Porter’s Five Forces Model Analysis

Figure 8: Europe ECMO Machine Market: Value Chain Analysis

Figure 9: Europe ECMO Machine Market Share Analysis, By Modality, 2024-2034

Figure 10: Europe ECMO Machine Market Share Analysis, By Patient Type, 2024-2034

Figure 11: Europe ECMO Machine Market Share Analysis, By Component, 2024-2034

Figure 12: Germany ECMO Machine Market Share Analysis, By Modality, 2024-2034

Figure 13: Germany ECMO Machine Market Share Analysis, By Patient Type, 2024-2034

Figure 14: Germany ECMO Machine Market Share Analysis, By Component, 2024-2034

Figure 15: U.K. ECMO Machine Market Share Analysis, By Modality, 2024-2034

Figure 16: U.K. ECMO Machine Market Share Analysis, By Patient Type, 2024-2034

Figure 17: U.K. ECMO Machine Market Share Analysis, By Component, 2024-2034

Figure 18: France ECMO Machine Market Share Analysis, By Modality, 2024-2034

Figure 19: France ECMO Machine Market Share Analysis, By Patient Type, 2024-2034

Figure 20: France ECMO Machine Market Share Analysis, By Component, 2024-2034

Figure 21: Italy ECMO Machine Market Share Analysis, By Modality, 2024-2034

Figure 22: Italy ECMO Machine Market Share Analysis, By Patient Type, 2024-2034

Figure 23: Italy ECMO Machine Market Share Analysis, By Component, 2024-2034

Figure 24: Spain ECMO Machine Market Share Analysis, By Modality, 2024-2034

Figure 25: Spain ECMO Machine Market Share Analysis, By Patient Type, 2024-2034

Figure 26: Spain ECMO Machine Market Share Analysis, By Component, 2024-2034

Figure 27: Rest of Europe ECMO Machine Market Share Analysis, By Modality, 2024-2034

Figure 28: Rest of Europe ECMO Machine Market Share Analysis, By Patient Type, 2024-2034

Figure 29: Rest of Europe ECMO Machine Market Share Analysis, By Component, 2024-2034

Figure 30: Europe ECMO Machine Market: Competitive Benchmarking

Figure 31: Europe ECMO Machine Market: Vendor Share Analysis, 2024

Figure 32: Europe ECMO Machine Market: Regulatory Landscape

Figure 33: Europe ECMO Machine Market: Technological Innovations

Figure 34: Europe ECMO Machine Market: Future Outlook

Figure 35: Europe ECMO Machine Market: Forecast Methodology

Figure 36: Europe ECMO Machine Market: Regional Demand Distribution

Figure 37: Europe ECMO Machine Market: Price Trends and Forecast

Figure 38: Europe ECMO Machine Market: Supply Chain Analysis

Figure 39: Europe ECMO Machine Market: Hospital Adoption Trends

Figure 40: Europe ECMO Machine Market: Market Entry Strategies

Key Players: (this may not be a complete list and extra companies can be added upon request)

 

Medtronic Plc

Getinge AB

LivaNova Plc

Terumo Corporation

MicroPort Scientific Corporation

Abbott Laboratories

Fresenius Medical Care AG & Co. KGaA

Xenios AG (A Fresenius Company)

Eurosets Srl

Nipro Corporation

Choose License Type

  • Single user license: $3,465.00
  • Multi user license: $4,465.00
  • Corporate license: $5,465.00
Request Sample

Discounts available for multiple report purchases.

  • Comprehensive
    Research Study

    Navigate market complexities confidently with our thorough research study, illuminating pathways to success for your business.

  • Security &
    Confidentiality

    We employ robust security measures to protect your data, ensuring peace of mind throughout the research process.

  • Service
    Assurance

    We uphold the highest standards of integrity and professionalism, delivering trustworthy insights you can depend on.